CAS RN: 916326-80-2
Methyl 5-bromo-1-methyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylate
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250709
250mg
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 916326-80-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
916326-80-2 / methyl 5-bromo-1-methylpyrazolo[5,4-b]pyridine-3-carboxylate
Standard CAS: 916326-80-2
Multi CAS: No
Basic Information
copy
CAS
916326-80-2 copy
Multi CAS
No copy
Molecular Formula
BC9H8O2Rn3 copy
Molecular Weight
270.080000 copy
Exact Mass
268.979990 copy
InChI
InChI=1S/C9H8BrN3O2/c1-13-8-6(3-5(10)4-11-8)7(12-13)9(14)15-2/h3-4H,1-2H3 copy
InChIKey
GGILHBFZRKBNSR-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
9 copy
Fraction Csp3
0.22 copy
Rotatable bonds
1 copy
H-bond acceptors
5 copy
Molar refractivity
57.55 copy
TPSA
57.01 copy
LogP / Solubility
WLOGP
1.52 copy
MLOGP
1.34 copy
XLogP3
1.7 copy
Consensus LogP
1.52 copy
Log S (ESOL)
-2.85 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.87 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.8 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.29 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy